FL_genes.md
... ...
@@ -14,55 +14,55 @@ link-citations: true
14 14
### *49 total*
15 15
16 16
|Gene|Summary| First FL study | Other entities | QC result |
17
-|:-:|:-:|:-:|:-|:-|
18
-|[ARID1A](ARID1A)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@barisicARID1AOrchestratesSWI2024] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@loveGeneticLandscapeMutations2012; @rossiCodingGenomeSplenic2012c; @wienandGenomicAnalysesFlowsorted2019b; @zhangGeneticHeterogeneityDiffuse2013]||
17
+|:-:|:--:|:-:|:-|:-|
18
+|[ARID1A](ARID1A)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@barisicARID1AOrchestratesSWI2024], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@loveGeneticLandscapeMutations2012; @rossiCodingGenomeSplenic2012c; @wienandGenomicAnalysesFlowsorted2019b; @zhangGeneticHeterogeneityDiffuse2013]||
19 19
|[ATP6AP1](ATP6AP1)|Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a]|[Okosun et al](papers/okosunRecurrentMTORC1activatingRRAGC2016a)|||
20 20
|[ATP6V1B2](ATP6V1B2)|Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a]|[Okosun et al](papers/okosunRecurrentMTORC1activatingRRAGC2016a)|||
21
-|[B2M](B2M)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@challa-malladiCombinedGeneticInactivationa] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@pararajalingamCodingNoncodingDrivers2020; @reichelFlowSortingExome2015a]||
22
-|[BCL2](BCL2)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@balSuperenhancerHypermutationAlters2022] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@burkhardtClinicalRelevanceMolecular2022b; @sarkozyMutationalLandscapeGray2021a; @tanakaFrequentIncidenceSomatic1992]||
23
-|[BCL7A](BCL7A)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@balinas-gaviraFrequentMutationsAminoterminal2020b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@grandeGenomewideDiscoverySomatic2019; @morinFrequentMutationHistonemodifying2011; @reichelFlowSortingExome2015a]||
24
-|[BTK](BTK)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@albuquerqueEnhancingKnowledgeDiscovery2017a]||
25
-|[CARD11](CARD11)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@lenzOncogenicCARD11Mutations2008], CE[@zhaoExpressionPrognosticValue2016] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@lenzOncogenicCARD11Mutations2008; @wuGeneticHeterogeneityPrimary2016; @yanBCRTLRSignaling2012a]||
26
-|[CCND3](CCND3)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@schmitzBurkittLymphomaPathogenesis2012] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@deschGenotypingCirculatingTumor2020; @jalladesExomeSequencingIdentifies2017; @richterRecurrentMutationID32012a]||
27
-|[CD83](CD83)|Tier 1 GE[@russler-germainMutationsAssociatedProgression2023b] (aSHM)|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@dunsCharacterizationDLBCLPMBL2021b; @morinMutationalStructuralAnalysis2013; @paneaWholeGenomeLandscape2019]||
28
-|[CREBBP](CREBBP)|Tier 1 GE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011a] (aSHM)|[Pasqualucci et al](papers/pasqualucciInactivatingMutationsAcetyltransferase2011a)|[@dunsCharacterizationDLBCLPMBL2021b; @loveGeneticLandscapeMutations2012; @parryWholeExomeSequencing2013]||
21
+|[B2M](B2M)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@challa-malladiCombinedGeneticInactivationa], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@pararajalingamCodingNoncodingDrivers2020; @reichelFlowSortingExome2015a]||
22
+|[BCL2](BCL2)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@balSuperenhancerHypermutationAlters2022], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@burkhardtClinicalRelevanceMolecular2022b; @sarkozyMutationalLandscapeGray2021a; @tanakaFrequentIncidenceSomatic1992]||
23
+|[BCL7A](BCL7A)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@balinas-gaviraFrequentMutationsAminoterminal2020b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@grandeGenomewideDiscoverySomatic2019; @morinFrequentMutationHistonemodifying2011; @reichelFlowSortingExome2015a]||
24
+|[BTK](BTK)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@albuquerqueEnhancingKnowledgeDiscovery2017a]||
25
+|[CARD11](CARD11)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@lenzOncogenicCARD11Mutations2008], CE[@zhaoExpressionPrognosticValue2016], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@lenzOncogenicCARD11Mutations2008; @wuGeneticHeterogeneityPrimary2016; @yanBCRTLRSignaling2012a]||
26
+|[CCND3](CCND3)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@schmitzBurkittLymphomaPathogenesis2012], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@deschGenotypingCirculatingTumor2020; @jalladesExomeSequencingIdentifies2017; @richterRecurrentMutationID32012a]||
27
+|[CD83](CD83)|Tier 1 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@dunsCharacterizationDLBCLPMBL2021b; @morinMutationalStructuralAnalysis2013; @paneaWholeGenomeLandscape2019]||
28
+|[CREBBP](CREBBP)|Tier 1 GE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], aSHM|[Pasqualucci et al](papers/pasqualucciInactivatingMutationsAcetyltransferase2011a)|[@dunsCharacterizationDLBCLPMBL2021b; @loveGeneticLandscapeMutations2012; @parryWholeExomeSequencing2013]||
29 29
|[CTSS](CTSS)|Tier 1 GE[@barariaCathepsinAlterationsInduce2020c]|[Bararia et al](papers/barariaCathepsinAlterationsInduce2020c)|||
30
-|[EEF1A1](EEF1A1)|Tier 1 GE[@hubschmannMutationalMechanismsShaping2021b], CE[@gongExpressionClinicalValue2021] (aSHM)|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@reichelFlowSortingExome2015a]||
31
-|[EP300](EP300)|Tier 1 GE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011a] (aSHM)|[Pasqualucci et al](papers/pasqualucciInactivatingMutationsAcetyltransferase2011a)|[@rossiCodingGenomeSplenic2012c]||
32
-|[EZH2](EZH2)|Tier 1 GE[@morinSomaticMutationsAltering2010a], FE[@yapSomaticMutationsEZH22011b] (aSHM)|[Morin et al](papers/morinSomaticMutationsAltering2010a)|[@loveGeneticLandscapeMutations2012; @mottokIntegrativeGenomicAnalysis2019b]||
33
-|[FOXO1](FOXO1)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@trinhAnalysisFOXO1Mutations], CE[@trinhAnalysisFOXO1Mutations] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@dunsCharacterizationDLBCLPMBL2021b; @schmitzBurkittLymphomaPathogenesis2012]||
34
-|[GNA13](GNA13)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@muppidiLossSignalingGa132014b] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@loveGeneticLandscapeMutations2012; @reichelFlowSortingExome2015a]||
35
-|[HIST1H1B](HIST1H1B)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b; @sarkozyMutationalLandscapeGray2021a]||
36
-|[HIST1H1C](HIST1H1C)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@paneaWholeGenomeLandscape2019]||
37
-|[HIST1H1D](HIST1H1D)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@jalladesExomeSequencingIdentifies2017; @morinMutationalStructuralAnalysis2013]||
38
-|[HIST1H1E](HIST1H1E)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@grandeGenomewideDiscoverySomatic2019; @lohrDiscoveryPrioritizationSomatic2012a; @reichelFlowSortingExome2015a]||
39
-|[HIST1H2AC](HIST1H2AC)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@morinMutationalStructuralAnalysis2013]||
40
-|[HIST1H2AG](HIST1H2AG)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@morinMutationalStructuralAnalysis2013; @paneaWholeGenomeLandscape2019; @rossiCodingGenomeSplenic2012c]||
41
-|[HIST1H2AM](HIST1H2AM)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b; @paneaWholeGenomeLandscape2019]||
42
-|[HIST1H2BC](HIST1H2BC)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@lohrDiscoveryPrioritizationSomatic2012a; @mottokIntegrativeGenomicAnalysis2019b]||
30
+|[EEF1A1](EEF1A1)|Tier 1 GE[@hubschmannMutationalMechanismsShaping2021b], CE[@gongExpressionClinicalValue2021], aSHM|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@reichelFlowSortingExome2015a]||
31
+|[EP300](EP300)|Tier 1 GE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011a], aSHM|[Pasqualucci et al](papers/pasqualucciInactivatingMutationsAcetyltransferase2011a)|[@rossiCodingGenomeSplenic2012c]||
32
+|[EZH2](EZH2)|Tier 1 GE[@morinSomaticMutationsAltering2010a], FE[@yapSomaticMutationsEZH22011b], aSHM|[Morin et al](papers/morinSomaticMutationsAltering2010a)|[@loveGeneticLandscapeMutations2012; @mottokIntegrativeGenomicAnalysis2019b]||
33
+|[FOXO1](FOXO1)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@trinhAnalysisFOXO1Mutations], CE[@trinhAnalysisFOXO1Mutations], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@dunsCharacterizationDLBCLPMBL2021b; @schmitzBurkittLymphomaPathogenesis2012]||
34
+|[GNA13](GNA13)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@muppidiLossSignalingGa132014b], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@loveGeneticLandscapeMutations2012; @reichelFlowSortingExome2015a]||
35
+|[HIST1H1B](HIST1H1B)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b; @sarkozyMutationalLandscapeGray2021a]||
36
+|[HIST1H1C](HIST1H1C)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@paneaWholeGenomeLandscape2019]||
37
+|[HIST1H1D](HIST1H1D)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@jalladesExomeSequencingIdentifies2017; @morinMutationalStructuralAnalysis2013]||
38
+|[HIST1H1E](HIST1H1E)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@grandeGenomewideDiscoverySomatic2019; @lohrDiscoveryPrioritizationSomatic2012a; @reichelFlowSortingExome2015a]||
39
+|[HIST1H2AC](HIST1H2AC)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@morinMutationalStructuralAnalysis2013]||
40
+|[HIST1H2AG](HIST1H2AG)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@morinMutationalStructuralAnalysis2013; @paneaWholeGenomeLandscape2019; @rossiCodingGenomeSplenic2012c]||
41
+|[HIST1H2AM](HIST1H2AM)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b; @paneaWholeGenomeLandscape2019]||
42
+|[HIST1H2BC](HIST1H2BC)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@lohrDiscoveryPrioritizationSomatic2012a; @mottokIntegrativeGenomicAnalysis2019b]||
43 43
|[HIST1H2BD](HIST1H2BD)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|||
44 44
|[HIST1H2BG](HIST1H2BG)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|||
45
-|[HIST1H3B](HIST1H3B)|Tier 1 GE (aSHM)||[@lohrDiscoveryPrioritizationSomatic2012a; @reichelFlowSortingExome2015a]||
45
+|[HIST1H3B](HIST1H3B)|Tier 1 GE, aSHM||[@lohrDiscoveryPrioritizationSomatic2012a; @reichelFlowSortingExome2015a]||
46 46
|[HIST1H3G](HIST1H3G)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|||
47
-|[HVCN1](HVCN1)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b]||
48
-|[IRF4](IRF4)|Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @mottokIntegrativeGenomicAnalysis2019b]||
49
-|[IRF8](IRF8)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@qiuIRF8mutantCellLymphoma2024] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@mottokIntegrativeGenomicAnalysis2019b; @paneaWholeGenomeLandscape2019]||
50
-|[KLHL6](KLHL6)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@merirantaDisruptionKLHL6Fuels2024] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@ganapathiGeneticLandscapeDural2016]||
51
-|[KMT2D](KMT2D)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@liLossCREBBPKMT2D2024], CE[@rushtonGeneticEvolutionaryPatterns2020] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@beaLandscapeSomaticMutations2013; @deschGenotypingCirculatingTumor2020; @grandeGenomewideDiscoverySomatic2019; @rossiCodingGenomeSplenic2012c]||
52
-|[MAP2K1](MAP2K1)|Tier 1 GE[@louissaintPediatrictypeNodalFollicular2016a] (aSHM)|[Louissaint et al](papers/louissaintPediatrictypeNodalFollicular2016a)|[@shinBRAFV600EMAP2K12015]||
53
-|[MEF2B](MEF2B)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@yingMEF2BMutationsLead] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@beaLandscapeSomaticMutations2013]||
54
-|[PIM1](PIM1)|Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023], CE[@guoSGK1MutationStatus2022b] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@burkhardtClinicalRelevanceMolecular2022b; @dunsCharacterizationDLBCLPMBL2021b; @pasqualucciHypermutationMultipleProtooncogenes2001a]||
55
-|[POU2AF1](POU2AF1)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b]||
56
-|[POU2F2](POU2F2)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@hodsonRegulationNormalBcell2016a] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@lohrDiscoveryPrioritizationSomatic2012a]||
57
-|[RRAGC](RRAGC)|Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a], FE[@ortega-molinaOncogenicRagGTPase2019b] (aSHM)|[Okosun et al](papers/okosunRecurrentMTORC1activatingRRAGC2016a)|||
58
-|[SGK1](SGK1)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@hartmannHighlyRecurrentMutations2016b], CE[@guoSGK1MutationStatus2022b] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@dunsCharacterizationDLBCLPMBL2021b]||
59
-|[SMARCA4](SMARCA4)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@dengSMARCA4HaploinsufficientCell2024] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@nadeuGenomicEpigenomicInsights2020b; @reddyGeneticFunctionalDrivers2017; @richterRecurrentMutationID32012a]||
60
-|[STAT6](STAT6)|Tier 1 GE[@yildizActivatingSTAT6Mutations2015c], FE[@yildizActivatingSTAT6Mutations2015c] (aSHM)|[Yildiz et al](papers/yildizActivatingSTAT6Mutations2015c)|[@ritzRecurrentMutationsSTAT62009a]||
61
-|[TBL1XR1](TBL1XR1)|Tier 1 GE, FE[@venturuttiTBL1XR1MutationsDrive2020b] (aSHM)||[@lohrDiscoveryPrioritizationSomatic2012a; @rossiCodingGenomeSplenic2012c]||
62
-|[TMSB4X](TMSB4X)|Tier 1 GE (aSHM)||[@zhangGeneticHeterogeneityDiffuse2013]||
63
-|[TNFAIP3](TNFAIP3)|Tier 1 GE, FE[@compagnoMutationsMultipleGenes2009a] (aSHM)||[@compagnoMutationsMultipleGenes2009a; @rossiAlterationBIRC3Multiple2011a; @schmitzTNFAIP3A20Tumor2009a]||
64
-|[TNFRSF14](TNFRSF14)|Tier 1 GE[@cheungAcquiredTNFRSF14Mutations2010a], CE[@guoSGK1MutationStatus2022b] (aSHM)|[Cheung et al](papers/cheungAcquiredTNFRSF14Mutations2010a)|[@morinFrequentMutationHistonemodifying2011; @spinaGeneticsNodalMarginal2016b]||
65
-|[TP53](TP53)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@rowhTp53DeletionLineage2011] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@beaLandscapeSomaticMutations2013; @lohrDiscoveryPrioritizationSomatic2012a; @rossiCodingGenomeSplenic2012c; @tiacciPervasiveMutationsJAKSTAT2018b; @wildaInactivationARFMDM2p53Pathway2004]||
47
+|[HVCN1](HVCN1)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b]||
48
+|[IRF4](IRF4)|Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @mottokIntegrativeGenomicAnalysis2019b]||
49
+|[IRF8](IRF8)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@qiuIRF8mutantCellLymphoma2024], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@mottokIntegrativeGenomicAnalysis2019b; @paneaWholeGenomeLandscape2019]||
50
+|[KLHL6](KLHL6)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@merirantaDisruptionKLHL6Fuels2024], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@ganapathiGeneticLandscapeDural2016]||
51
+|[KMT2D](KMT2D)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@liLossCREBBPKMT2D2024], CE[@rushtonGeneticEvolutionaryPatterns2020], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@beaLandscapeSomaticMutations2013; @deschGenotypingCirculatingTumor2020; @grandeGenomewideDiscoverySomatic2019; @rossiCodingGenomeSplenic2012c]||
52
+|[MAP2K1](MAP2K1)|Tier 1 GE[@louissaintPediatrictypeNodalFollicular2016a], aSHM|[Louissaint et al](papers/louissaintPediatrictypeNodalFollicular2016a)|[@shinBRAFV600EMAP2K12015]||
53
+|[MEF2B](MEF2B)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@yingMEF2BMutationsLead], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@beaLandscapeSomaticMutations2013]||
54
+|[PIM1](PIM1)|Tier 1 GE[@drevalGeneticSubdivisionsFollicular2023], CE[@guoSGK1MutationStatus2022b], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@burkhardtClinicalRelevanceMolecular2022b; @dunsCharacterizationDLBCLPMBL2021b; @pasqualucciHypermutationMultipleProtooncogenes2001a]||
55
+|[POU2AF1](POU2AF1)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@chapuyMolecularSubtypesDiffuse2018b]||
56
+|[POU2F2](POU2F2)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@hodsonRegulationNormalBcell2016a], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@lohrDiscoveryPrioritizationSomatic2012a]||
57
+|[RRAGC](RRAGC)|Tier 1 GE[@okosunRecurrentMTORC1activatingRRAGC2016a], FE[@ortega-molinaOncogenicRagGTPase2019b], aSHM|[Okosun et al](papers/okosunRecurrentMTORC1activatingRRAGC2016a)|||
58
+|[SGK1](SGK1)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@hartmannHighlyRecurrentMutations2016b], CE[@guoSGK1MutationStatus2022b], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@dunsCharacterizationDLBCLPMBL2021b]||
59
+|[SMARCA4](SMARCA4)|Tier 1 GE[@krysiakRecurrentSomaticMutations2017b], FE[@dengSMARCA4HaploinsufficientCell2024], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@nadeuGenomicEpigenomicInsights2020b; @reddyGeneticFunctionalDrivers2017; @richterRecurrentMutationID32012a]||
60
+|[STAT6](STAT6)|Tier 1 GE[@yildizActivatingSTAT6Mutations2015c], FE[@yildizActivatingSTAT6Mutations2015c], aSHM|[Yildiz et al](papers/yildizActivatingSTAT6Mutations2015c)|[@ritzRecurrentMutationsSTAT62009a]||
61
+|[TBL1XR1](TBL1XR1)|Tier 1 GE, FE[@venturuttiTBL1XR1MutationsDrive2020b], aSHM||[@lohrDiscoveryPrioritizationSomatic2012a; @rossiCodingGenomeSplenic2012c]||
62
+|[TMSB4X](TMSB4X)|Tier 1 GE, aSHM||[@zhangGeneticHeterogeneityDiffuse2013]||
63
+|[TNFAIP3](TNFAIP3)|Tier 1 GE, FE[@compagnoMutationsMultipleGenes2009a], aSHM||[@compagnoMutationsMultipleGenes2009a; @rossiAlterationBIRC3Multiple2011a; @schmitzTNFAIP3A20Tumor2009a]||
64
+|[TNFRSF14](TNFRSF14)|Tier 1 GE[@cheungAcquiredTNFRSF14Mutations2010a], CE[@guoSGK1MutationStatus2022b], aSHM|[Cheung et al](papers/cheungAcquiredTNFRSF14Mutations2010a)|[@morinFrequentMutationHistonemodifying2011; @spinaGeneticsNodalMarginal2016b]||
65
+|[TP53](TP53)|Tier 1 GE[@morinFrequentMutationHistonemodifying2011], FE[@rowhTp53DeletionLineage2011], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|[@beaLandscapeSomaticMutations2013; @lohrDiscoveryPrioritizationSomatic2012a; @rossiCodingGenomeSplenic2012c; @tiacciPervasiveMutationsJAKSTAT2018b; @wildaInactivationARFMDM2p53Pathway2004]||
66 66
|[VMA21](VMA21)|Tier 1 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
67 67
68 68
## Tier 2 FL genes
... ...
@@ -70,78 +70,78 @@ link-citations: true
70 70
### *64 total*
71 71
72 72
|Gene|Summary| First FL study | Other entities | QC result |
73
-|:-:|:-:|:-:|:-|:-|
73
+|:-:|:--:|:-:|:-|:-|
74 74
|[ABL2](ABL2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
75
-|[ACTB](ACTB)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@lohrDiscoveryPrioritizationSomatic2012a; @wienandGenomicAnalysesFlowsorted2019b]||
76
-|[ACTG1](ACTG1)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] (aSHM)|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@deschGenotypingCirculatingTumor2020; @spinaGeneticsNodalMarginal2016b]||
75
+|[ACTB](ACTB)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@lohrDiscoveryPrioritizationSomatic2012a; @wienandGenomicAnalysesFlowsorted2019b]||
76
+|[ACTG1](ACTG1)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b], aSHM|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@deschGenotypingCirculatingTumor2020; @spinaGeneticsNodalMarginal2016b]||
77 77
|[ATP6V1A](ATP6V1A)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
78
-|[BCL10](BCL10)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], FE[@xiaBCL10MutationsDefine2022] (aSHM)|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@morinFrequentMutationHistonemodifying2011; @spinaGeneticsNodalMarginal2016b]||
79
-|[BCL6](BCL6)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@balSuperenhancerHypermutationAlters2022] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@loveGeneticLandscapeMutations2012; @morinFrequentMutationHistonemodifying2011]||
80
-|[BIRC6](BIRC6)|Tier 2 GE (aSHM)||[@reddyGeneticFunctionalDrivers2017; @sarkozyMutationalLandscapeGray2021a]||
81
-|[BTG1](BTG1)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@mlynarczykBTG1MutationYields2023b] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@burkhardtClinicalRelevanceMolecular2022b; @morinFrequentMutationHistonemodifying2011; @sarkozyMutationalLandscapeGray2021a]||
82
-|[BTG2](BTG2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], CE[@guoMutationBTG2Gene2022b] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@loveGeneticLandscapeMutations2012; @morinFrequentMutationHistonemodifying2011]||
83
-|[CD70](CD70)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] (aSHM)|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@morinFrequentMutationHistonemodifying2011]||
84
-|[CD79B](CD79B)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@davisChronicActiveBcellreceptor2010] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @paneaWholeGenomeLandscape2019]||
78
+|[BCL10](BCL10)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], FE[@xiaBCL10MutationsDefine2022], aSHM|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@morinFrequentMutationHistonemodifying2011; @spinaGeneticsNodalMarginal2016b]||
79
+|[BCL6](BCL6)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@balSuperenhancerHypermutationAlters2022], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@loveGeneticLandscapeMutations2012; @morinFrequentMutationHistonemodifying2011]||
80
+|[BIRC6](BIRC6)|Tier 2 GE, aSHM||[@reddyGeneticFunctionalDrivers2017; @sarkozyMutationalLandscapeGray2021a]||
81
+|[BTG1](BTG1)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@mlynarczykBTG1MutationYields2023b], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@burkhardtClinicalRelevanceMolecular2022b; @morinFrequentMutationHistonemodifying2011; @sarkozyMutationalLandscapeGray2021a]||
82
+|[BTG2](BTG2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], CE[@guoMutationBTG2Gene2022b], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@loveGeneticLandscapeMutations2012; @morinFrequentMutationHistonemodifying2011]||
83
+|[CD70](CD70)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@morinFrequentMutationHistonemodifying2011]||
84
+|[CD79B](CD79B)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@davisChronicActiveBcellreceptor2010], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @paneaWholeGenomeLandscape2019]||
85 85
|[CDC42BPB](CDC42BPB)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@spinaGeneticsNodalMarginal2016b]||
86 86
|[CILP](CILP)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
87 87
|[CPNE8](CPNE8)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
88
-|[CXCR4](CXCR4)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@khodabakhshiRecurrentTargetsAberrant2012; @paneaWholeGenomeLandscape2019]||
88
+|[CXCR4](CXCR4)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@khodabakhshiRecurrentTargetsAberrant2012; @paneaWholeGenomeLandscape2019]||
89 89
|[CYP2A6](CYP2A6)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
90
-|[DDX3X](DDX3X)|Tier 2 GE, FE[@gongSequentialInverseDysregulation2021], CE[@kizhakeyilDDX3XLossAdverse2021] (aSHM)||[@mottokIntegrativeGenomicAnalysis2019b; @reddyGeneticFunctionalDrivers2017; @schmitzBurkittLymphomaPathogenesis2012]||
90
+|[DDX3X](DDX3X)|Tier 2 GE, FE[@gongSequentialInverseDysregulation2021], CE[@kizhakeyilDDX3XLossAdverse2021], aSHM||[@mottokIntegrativeGenomicAnalysis2019b; @reddyGeneticFunctionalDrivers2017; @schmitzBurkittLymphomaPathogenesis2012]||
91 91
|[DHX15](DHX15)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
92
-|[DTX1](DTX1)|Tier 2 GE, FE[@demirandaExomeSequencingReveals2014], CE[@merirantaDeltex1MutationsPredict2017b] (aSHM)||[@gomezUltraDeepSequencingReveals2023; @loveGeneticLandscapeMutations2012; @rossiCodingGenomeSplenic2012c; @zhangGeneticHeterogeneityDiffuse2013]||
93
-|[DUSP2](DUSP2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@dunsCharacterizationDLBCLPMBL2021b; @lohrDiscoveryPrioritizationSomatic2012a]||
94
-|[EBF1](EBF1)|Tier 2 GE (aSHM)||[@bohleRoleEarlyBcell2013; @reichelFlowSortingExome2015a; @thomasGeneticSubgroupsInform2023]||
92
+|[DTX1](DTX1)|Tier 2 GE, FE[@demirandaExomeSequencingReveals2014], CE[@merirantaDeltex1MutationsPredict2017b], aSHM||[@gomezUltraDeepSequencingReveals2023; @loveGeneticLandscapeMutations2012; @rossiCodingGenomeSplenic2012c; @zhangGeneticHeterogeneityDiffuse2013]||
93
+|[DUSP2](DUSP2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@dunsCharacterizationDLBCLPMBL2021b; @lohrDiscoveryPrioritizationSomatic2012a]||
94
+|[EBF1](EBF1)|Tier 2 GE, aSHM||[@bohleRoleEarlyBcell2013; @reichelFlowSortingExome2015a; @thomasGeneticSubgroupsInform2023]||
95 95
|[EGR1](EGR1)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@reichelFlowSortingExome2015a; @rossiCodingGenomeSplenic2012c]||
96
-|[FAS](FAS)|Tier 2 GE, FE[@seebergerLossFasCD952001] (aSHM)||[@schollMutationsRegionFAS2007; @spinaGeneticsNodalMarginal2016b]||
96
+|[FAS](FAS)|Tier 2 GE, FE[@seebergerLossFasCD952001], aSHM||[@schollMutationsRegionFAS2007; @spinaGeneticsNodalMarginal2016b]||
97 97
|[FZR1](FZR1)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
98 98
|[GBP7](GBP7)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
99
-|[GNAI2](GNAI2)|Tier 2 GE (aSHM)||[@grandeGenomewideDiscoverySomatic2019; @morinMutationalStructuralAnalysis2013]||
99
+|[GNAI2](GNAI2)|Tier 2 GE, aSHM||[@grandeGenomewideDiscoverySomatic2019; @morinMutationalStructuralAnalysis2013]||
100 100
|[GRM6](GRM6)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
101 101
|[HIST1H2BM](HIST1H2BM)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|||
102 102
|[HIST1H3I](HIST1H3I)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b]|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@paneaWholeGenomeLandscape2019]||
103
-|[HLA-B](HLA-B)|Tier 2 GE (aSHM)||[@lohrDiscoveryPrioritizationSomatic2012a; @wienandGenomicAnalysesFlowsorted2019b]||
104
-|[IGLL5](IGLL5)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] (aSHM)|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@chapuyMolecularSubtypesDiffuse2018b; @deschGenotypingCirculatingTumor2020; @paneaWholeGenomeLandscape2019]||
105
-|[ITPKB](ITPKB)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@reichelFlowSortingExome2015a; @schmitzGeneticsPathogenesisDiffuse2018a]||
103
+|[HLA-B](HLA-B)|Tier 2 GE, aSHM||[@lohrDiscoveryPrioritizationSomatic2012a; @wienandGenomicAnalysesFlowsorted2019b]||
104
+|[IGLL5](IGLL5)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@chapuyMolecularSubtypesDiffuse2018b; @deschGenotypingCirculatingTumor2020; @paneaWholeGenomeLandscape2019]||
105
+|[ITPKB](ITPKB)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@reichelFlowSortingExome2015a; @schmitzGeneticsPathogenesisDiffuse2018a]||
106 106
|[JUP](JUP)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
107 107
|[KIR3DL1](KIR3DL1)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
108
-|[KLF2](KLF2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@deschGenotypingCirculatingTumor2020; @jalladesExomeSequencingIdentifies2017; @pasqualucciAnalysisCodingGenome2011]||
109
-|[LAPTM5](LAPTM5)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] (aSHM)|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
110
-|[LTB](LTB)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@chapuyMolecularSubtypesDiffuse2018b; @deschGenotypingCirculatingTumor2020]||
108
+|[KLF2](KLF2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@deschGenotypingCirculatingTumor2020; @jalladesExomeSequencingIdentifies2017; @pasqualucciAnalysisCodingGenome2011]||
109
+|[LAPTM5](LAPTM5)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b], aSHM|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
110
+|[LTB](LTB)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@chapuyMolecularSubtypesDiffuse2018b; @deschGenotypingCirculatingTumor2020]||
111 111
|[MAGEC1](MAGEC1)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
112 112
|[MAP7D1](MAP7D1)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
113
-|[MEF2C](MEF2C)|Tier 2 GE, FE[@jingjingNovelMEF2CMutation2020] (aSHM)||[@arthurGenomewideDiscoverySomatic2018]||
113
+|[MEF2C](MEF2C)|Tier 2 GE, FE[@jingjingNovelMEF2CMutation2020], aSHM||[@arthurGenomewideDiscoverySomatic2018]||
114 114
|[MGEA5](MGEA5)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
115 115
|[MKI67](MKI67)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@schmitzBurkittLymphomaPathogenesis2012]||
116
-|[MYC](MYC)|Tier 2 GE, FE[@giallongoIdentificationCmycOncogene1983], CE[@christieCMYCTranslocation142008] (aSHM)||[@dunsCharacterizationDLBCLPMBL2021b; @jalladesExomeSequencingIdentifies2017; @johnstonCmycHypermutationBurkitt1992; @pasqualucciHypermutationMultipleProtooncogenes2001a]||
116
+|[MYC](MYC)|Tier 2 GE, FE[@giallongoIdentificationCmycOncogene1983], CE[@christieCMYCTranslocation142008], aSHM||[@dunsCharacterizationDLBCLPMBL2021b; @jalladesExomeSequencingIdentifies2017; @johnstonCmycHypermutationBurkitt1992; @pasqualucciHypermutationMultipleProtooncogenes2001a]||
117 117
|[MYCBP2](MYCBP2)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
118
-|[MYD88](MYD88)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@ngoOncogenicallyActiveMYD882011a], CE[@guoSGK1MutationStatus2022b] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@ngoOncogenicallyActiveMYD882011a; @yanBCRTLRSignaling2012a]||
119
-|[NFKBIA](NFKBIA)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] (aSHM)|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@thomasMutationalAnalysisIkappaBalpha2004; @wienandGenomicAnalysesFlowsorted2019b]||
118
+|[MYD88](MYD88)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@ngoOncogenicallyActiveMYD882011a], CE[@guoSGK1MutationStatus2022b], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@ngoOncogenicallyActiveMYD882011a; @yanBCRTLRSignaling2012a]||
119
+|[NFKBIA](NFKBIA)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@thomasMutationalAnalysisIkappaBalpha2004; @wienandGenomicAnalysesFlowsorted2019b]||
120 120
|[OR8H2](OR8H2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
121
-|[P2RY8](P2RY8)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@muppidiLossSignalingGa132014b] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@lohrDiscoveryPrioritizationSomatic2012a; @muppidiLossSignalingGa132014b]||
122
-|[PDS5B](PDS5B)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] (aSHM)|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@morinMutationalStructuralAnalysis2013]||
121
+|[P2RY8](P2RY8)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@muppidiLossSignalingGa132014b], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@lohrDiscoveryPrioritizationSomatic2012a; @muppidiLossSignalingGa132014b]||
122
+|[PDS5B](PDS5B)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b], aSHM|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@morinMutationalStructuralAnalysis2013]||
123 123
|[PPP4C](PPP4C)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
124
-|[PRKDC](PRKDC)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b] (aSHM)|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@schmitzGeneticsPathogenesisDiffuse2018a]||
125
-|[PTPRD](PTPRD)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@spinaGeneticsNodalMarginal2016b]||
124
+|[PRKDC](PRKDC)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b], aSHM|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|[@schmitzGeneticsPathogenesisDiffuse2018a]||
125
+|[PTPRD](PTPRD)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@spinaGeneticsNodalMarginal2016b]||
126 126
|[PZP](PZP)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
127 127
|[RBM6](RBM6)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
128
-|[S1PR2](S1PR2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@floriHematopoieticOncoproteinFOXP12016] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @muppidiLossSignalingGa132014b]||
128
+|[S1PR2](S1PR2)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@floriHematopoieticOncoproteinFOXP12016], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @muppidiLossSignalingGa132014b]||
129 129
|[SHROOM3](SHROOM3)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
130
-|[SOCS1](SOCS1)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@melznerBiallelicMutationSOCS12005a] (aSHM)|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @wenigerMutationsTumorSuppressor2006a]||
131
-|[SRRM2](SRRM2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b] (aSHM)|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@morinMutationalStructuralAnalysis2013]||
130
+|[SOCS1](SOCS1)|Tier 2 GE[@drevalGeneticSubdivisionsFollicular2023], FE[@melznerBiallelicMutationSOCS12005a], aSHM|[Dreval et al](papers/drevalGeneticSubdivisionsFollicular2023)|[@morinFrequentMutationHistonemodifying2011; @wenigerMutationsTumorSuppressor2006a]||
131
+|[SRRM2](SRRM2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b], aSHM|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|[@morinMutationalStructuralAnalysis2013]||
132 132
|[STAB2](STAB2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
133
-|[TMEM30A](TMEM30A)|Tier 2 GE[@morinFrequentMutationHistonemodifying2011], FE[@ennishiTMEM30ALossoffunctionMutations2020b], CE[@ennishiTMEM30ALossoffunctionMutations2020b] (aSHM)|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|||
133
+|[TMEM30A](TMEM30A)|Tier 2 GE[@morinFrequentMutationHistonemodifying2011], FE[@ennishiTMEM30ALossoffunctionMutations2020b], CE[@ennishiTMEM30ALossoffunctionMutations2020b], aSHM|[Morin et al](papers/morinFrequentMutationHistonemodifying2011)|||
134 134
|[TPP1](TPP1)|Tier 2 GE[@hubschmannMutationalMechanismsShaping2021b]|[Hubschmann et al](papers/hubschmannMutationalMechanismsShaping2021b)|||
135 135
|[XIRP2](XIRP2)|Tier 2 GE[@russler-germainMutationsAssociatedProgression2023b]|[Russler et al](papers/russler-germainMutationsAssociatedProgression2023b)|||
136
-|[ZC3H12A](ZC3H12A)|Tier 2 GE (aSHM)||[@chapuyMolecularSubtypesDiffuse2018b]||
137
-|[ZNF608](ZNF608)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b] (aSHM)|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@morinMutationalStructuralAnalysis2013]||
136
+|[ZC3H12A](ZC3H12A)|Tier 2 GE, aSHM||[@chapuyMolecularSubtypesDiffuse2018b]||
137
+|[ZNF608](ZNF608)|Tier 2 GE[@krysiakRecurrentSomaticMutations2017b], aSHM|[Krysiak et al](papers/krysiakRecurrentSomaticMutations2017b)|[@morinMutationalStructuralAnalysis2013]||
138 138
139 139
## Tier 3 FL genes
140 140
141 141
### *0 total*
142 142
143 143
|Gene|Summary| First FL study | Other entities | QC result |
144
-|:-:|:-:|:-:|:-|:-|
144
+|:-:|:--:|:-:|:-|:-|
145 145
146 146
147 147
# References